HITshow Daily: September 5, 2025 (Friday)

The AMA recognizes 109 health systems for advancing physician well-being, 140+ providers and stakeholders press Congress for a long-term hospital-at-home waiver, and PhRMA launches an ad campaign on 340B markups ahead of Fierce Pharma Week. Plus, Parasym introduces a new non-invasive vagus nerve stimulation device, and Rimidi’s CEO Lucienne Ide explains how providers’ mindset around remote patient monitoring has evolved. HOST: Ida Klein The Day’s Pulse 📍 Workforce & Well-Being — Teresa VaughnThe American Medical Association awards Joy in Medicine® recognition to 109 hospitals and health systems for tackling burnout and building physician-friendly cultures. 📍 Providers & Policy — Anika Shah52 health systems push Congress to extend the hospital-at-home waiver through 2030, warning that without action this month, innovative care models could stall. 📍 Advocacy & Pharma — Logan StokesPhRMA launches a national ad campaign targeting 340B markups, setting the stage for debates at next week’s Fierce Pharma Week in Philadelphia. 📍 Innovation & Technology — Jade RomeroParasym launches Nuropod, a wearable vagus nerve stimulation device that’s non-invasive and surgery-free, with over 50 clinical studies showing reductions in fatigue, anxiety, and inflammation. 🎙️ Interview — Jalen Cross with Lucienne Ide, CEO of RimidiHow providers’ mindset around remote patient monitoring is changing—from “pilot project” to “part of the standard of care.” 🎧 Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit.show. Presented by: Altera Digital Health and Kimmchi